Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2984131000168119 | Litak 10 mg/5 mL injection, 5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
2984141000168111 | Litak (cladribine 10 mg / 5 mL) injection, 5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Litak 10 mg/5 mL injection, 5 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Litak 10 mg/5 mL injection, 5 mL vial | has Australian BoSS | cladribine | true | Inferred relationship | Some | 21251434 | |
Litak 10 mg/5 mL injection, 5 mL vial | has unit of use | vial | true | Inferred relationship | Some | 21251435 | |
Litak 10 mg/5 mL injection, 5 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Litak 10 mg/5 mL injection, 5 mL vial | Is a | Litak | true | Inferred relationship | Some | ||
Litak 10 mg/5 mL injection, 5 mL vial | Is a | cladribine 10 mg/5 mL injection, vial | true | Inferred relationship | Some | ||
Litak 10 mg/5 mL injection, 5 mL vial | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
Litak 10 mg/5 mL injection, 5 mL vial | has intended active ingredient | cladribine | true | Inferred relationship | Some | 21251434 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Litak 10 mg/5 mL injection, 5 mL vial | has TPUU | True | Litak 10 mg/5 mL injection, 5 mL vial | Inferred relationship | Some | 1 |
Litak 10 mg/5 mL injection, 5 mL vial | has TPUU | True | Litak 10 mg/5 mL injection, 5 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set